Scroll.in The US Food and Drug Administration has found a series of violations in the manufacturing process and sterilisation methods adopted by Global Pharma, the Indian manufacturer of an eye drop that has been linked to 68 cases of eye infection in America, including eight cases of vision loss and three deaths. The company recalled its product, EzriCare Artificial Tears Eye Drop, early in February. The over-the-counter product has been linked to...
More »SEARCH RESULT
Total Matching Records found : 59
Maharashtra FDA recalls batch of anti-anaemic medicine after alleged cases of adverse reactions
-Scroll.in One persons died in Mumbai after allegedly being administered with Orofer FCM. The Maharashtra Food and Drug Administration has announced that it will recall a batch of anti-anaemic medicine Orofer FCM after noting multiple incidents of alleged adverse reaction, including the suspected death of a 55-year-old man in Mumbai in September. Orofer FCM is manufactured by Pune-based Emcure Pharmaceuticals, which supplies medicines to 70 countries. It is administered in the form of...
More »For Poor Manufacturing Practices, Indian Pharma Company Gets ‘Warning Letter’ From US FDA
-TheWire.in The US drug regulator says Lupin Limited's response to tackling genotoxic impurities was not adequate. New Delhi: The US Food and Drug Administration (FDA) has sent a warning letter to the Indian pharmaceutical company Lupin Limited after deeming its efforts to address violations of various good manufacturing practices at its facility in Tarapur, Maharashtra “inadequate”. The FDA sends a ‘warning letter’ to a manufacturer if it has “significantly violated” the agency’s regulations....
More »Indian government did not request vaccines from the US -Sriram Lakshman
-The Hindu U.S. lawmakers and other influential voices have been calling for the U.S. to donate its spare vaccines to countries like India, particularly some of the tens of millions of doses of AstraZeneca vaccine. Washington DC: The Biden administration has said that the government of India did not request it for ready-to-use vaccines, as pressure has been mounting on the U.S. to give out vaccines to countries such as India, which...
More »The high price of Big Pharma greed -Leena Menghaney
-The Hindu In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, innovator of the drug, filed a suit against the Indian Food & Drug Administration (FDA) to block its sale. The action firmly put their profits ahead of the lives of women with breast cancer. Roche effectively embroiled India’s...
More »
